Ovid Therapeutics Inc. (OVID)
NASDAQ·Healthcare·Biotechnology
$2.73
+1.30%
Mkt Cap $354.77M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (5 analysts)
$2.50
Range $2.00 – $3.00
Implied Upside
-8.3%
Consensus $2.50 vs current $2.73
NASDAQ·Healthcare·Biotechnology
$2.73
+1.30%
Mkt Cap $354.77M
Buy
6
Hold
0
Sell
0
Price Target (5 analysts)
$2.50
Range $2.00 – $3.00
-8.3%
Consensus $2.50 vs current $2.73